Protease-activated receptors (PARs) are partly pro-inflammatory and partly anti-inflammatory: will PAR agonists or antagonists participate in future drug therapies?
about
Protease-activated receptors (PARs) are partly pro-inflammatory and partly anti-inflammatory: will PAR agonists or antagonists participate in future drug therapies?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Protease-activated receptors ( ...... pate in future drug therapies?
@ast
Protease-activated receptors ( ...... pate in future drug therapies?
@en
type
label
Protease-activated receptors ( ...... pate in future drug therapies?
@ast
Protease-activated receptors ( ...... pate in future drug therapies?
@en
prefLabel
Protease-activated receptors ( ...... pate in future drug therapies?
@ast
Protease-activated receptors ( ...... pate in future drug therapies?
@en
P1433
P1476
Protease-activated receptors ( ...... pate in future drug therapies?
@en
P2093
B A De Campo
P304
P356
10.2174/138945006776818656
P577
2006-05-01T00:00:00Z